Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
BQ-788 shows no agonistic activity up to 10 μM and competitively inhibits thevasoconstriction induced by an ETB-selective agonist (pA2
CID5721353 (Compound 79-6) specifically inhibits BCL6 repressor activity
AC 253 protects against oligomeric Aβ-induced increase in intracellular Ca2+
17)18)21-10-6-7-14-12(8-10)22-11-4-2-3-5-13(11)23(14
with rapid clearance and barely measurable bioavailability
10-DEBC hydrochloride 15453 BQ-788 shows no agonistic activityAkt functions as a key component in multiple signaling pathways to promote cell survival by mediating resistance to apoptosis. Akt inhibitor X is a cell permeable phenoxazine derivative that suppresses insulin like growth factor 1 (IGF 1) stimulated phosphorylation of Akt with an IC50 value of 1 2 M. This compound has been shown to block IGF 1 stimulated nuclear translocation of Akt in Rh1 cells and to inhibit the growth of Rh1, Rh18, and Rh30 cells
US$ 215.00
US$ 45.00
US$ 196.00
US$ 101.00
US$ 37.50
US$ 45.00
US$ 50.00
US$ 30.00
US$ 140.00